nderstanding the perceptions of Plasmodium vivax malaria and radical cure

• Conditions: P. vivax malaria

• Registration Number: TCTR20210315004
• Lead Sponsor: niversity of Oxford

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-15
• Study Completion: 2021-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

All participants:
1. Age at least 18 years old at the time of recruitment
2. Able to communicate in the local languages (Karen and Burmese)
3. Able and willing to provide written informed consent for study participation
IDI participants:
1. Patients who have completed a primaquine treatment regimen for P. vivax infection previously.
FGD participants:
1. Health care providers experienced in the treatment of P. vivax malaria.
2. Community leaders (non-medical) who are involved directly in their community's affairs and participate in local groups.

Exclusion Criteria

All participants:
1 Unable or unwilling to contribute to the study activities in a competent manner
2 If the investigator AND another member of the study team decides the participant should be excluded (i.e., if they are unwell)
3. When a conflict of interest is present (e.g. the participant is well known to the study team member who will be conducting the interview or group discussion)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Migrant experience of primaquine adherence at 5 months after interview Thematic analysis

Secondary Outcome Measures

Name	Time	Method
Challenges/barriers to primaquine adherence at 5 months after interview or discussion The constructs of the Social Cognitive Theory,Key behavioral changes at 5 months after interview or discussion The constructs of the Social Cognitive Theory